Evidence map›Paper›PMID 23777423›Full record

ArticleInorganic chemistry2013

Structural optimization of Zn(II)-activated magnetic resonance imaging probes.

Lauren M Matosziuk, Jonathan H Leibowitz, Marie C Heffern, Keith W MacRenaris, Mark A Ratner, Thomas J Meade

Abstract read
In one paragraph

Article in Inorganic chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Highly Potent MRI Contrast Agent Displaying Outstanding Sensitivity to Zinc Ions.Angewandte Chemie (International ed. in English) · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fluorinated EuChemical science · 2017
    Article
  8. Intramolecular Hydrogen Bonding Restricts Gd-Aqua-Ligand Dynamics.Angewandte Chemie (International ed. in English) · 2017
    Article
  9. Magnetic barcode imaging for contrast agents.Magnetic resonance in medicine · 2017
    Article
  10. Functional nanoparticles for magnetic resonance imaging.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lauren M MatosziukDepartments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, and ‡Department of Chemistry, and Materials Science and Engineering, Northwestern University , Evanston, Illinois 60208-3113, United States.
Jonathan H Leibowitz
Marie C Heffern
Keith W MacRenaris
Mark A Ratner
Thomas J Meade

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Theranostic Magnetic Nanostructures for the Molecular Imaging of CancerU54CA151880 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MIRKIN, CHAD A., ROSEN, STEVEN TERRY · 2010 to 2014
$11.5M
q-Modulated Magnetic Resonance Imaging Contrast AgentsR01EB005866 · NIBIB · NORTHWESTERN UNIVERSITY · PI MEADE, THOMAS J · 2005 to 2013
$2.2M
Zeiss PALM Laser Capture Microdissection SystemS10RR025624 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHEW, TENG-LEONG · 2009 to 2009
$252k
NCI NIH HHS P30 CA060553NCI NIH HHS U54 CA151880NCRR NIH HHS 1S10RR025624-01NCRR NIH HHS S10 RR025624NIBIB NIH HHS R01 EB005866NIBIB NIH HHS R01EB005866
6 · The paper itself

Abstract

We report the structural optimization and mechanistic investigation of a series of bioactivated magnetic resonance imaging contrast agents that transform from low relaxivity to high relaxivity in the presence of Zn(II). The change in relaxivity results from a structural transformation of the complex that alters the coordination environment about the Gd(III) center. Here, we have performed a series of systematic modifications to determine the structure that provides the optimal change in relaxivity in response to the presence of Zn(II). Relaxivity measurements in the presence and absence of Zn(II) were used in conjunction with measurements regarding water access (namely, number of water molecules bound) to the Gd(III) center and temperature-dependent (13)C NMR spectroscopy to determine how the coordination environment about the Gd(III) center is affected by the distance between the Zn(II)-binding domain and the Gd(III) chelate, the number of functional groups on the Zn(II)-binding domain, and the presence of Zn(II). The results of this study provide valuable insight into the design principles for future bioactivated magnetic resonance probes.

Indexed as

Chelating AgentsChemistry Techniques, SyntheticContrast MediaGadoliniumMagnetic Resonance ImagingMagnetic Resonance SpectroscopyStructure-Activity RelationshipTemperatureZincChelating AgentsContrast MediaGadoliniumZinc

Identifiers

PMID23777423
PMCPMC3805786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.